<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty patients with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were examined; <z:hpo ids='HP_0000001'>all</z:hpo> but 2 were untreated or had not recently received therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Sister chromatid exchange (SCE) and cell progression through to the third mitotic cycle after phytohemagglutinin stimulation did not differ according to <z:hpo ids='HP_0002665'>lymphoma</z:hpo> type or disease stage, and the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> group as a whole did not differ from 20 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="2" pm="."><plain>These findings are contrary to other recent studies of SCE in malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The only patient who had received recent chemotherapy had the highest SCE score and a greatly accelerated cell cycle response </plain></SENT>
</text></document>